Back
Akari Therapeutics PLC Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
25
AKTX
Akari Therapeutics PLC
Last Price:
2.30
Seasonality Move:
-8%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereAkari Therapeutics PLC Price Quote
$2.30
+0.06 (+0%)
(Updated: November 14, 2024 at 5:05 AM ET)
Akari Therapeutics PLC Key Stats
Sell
25
Akari Therapeutics PLC (AKTX)
is a Sell
Day range:
$2.23 - $2.39
52-week range:
$1.08 - $4.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
5.5K
Avg. volume:
14.6K
1-year change:
-34.12%
Market cap:
$26.8M
Revenue:
$0
EPS:
$-2.16
How Much Does Akari Therapeutics PLC Make?
Data Unavailable
Is Akari Therapeutics PLC Growing As A Company?
Data Unavailable
Akari Therapeutics PLC Stock Price Performance
-
Did Akari Therapeutics PLC Stock Go Up Last Month?
Akari Therapeutics PLC share price went down by -17.04% last month -
Did AKTX's Share Price Rise Over The Last Year?
AKTX share price fell by -34.12% over the past 1 year
What Is Akari Therapeutics PLC 52-Week High & Low?
-
What Is Akari Therapeutics PLC’s 52-Week High Share Price?
Akari Therapeutics PLC has traded as high as $4.40 over the past 52 weeks -
What Is Akari Therapeutics PLC’s 52-Week Low Share Price?
Akari Therapeutics PLC has traded as low as $1.08 over the past 52 weeks
Akari Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akari Therapeutics PLC?
-
How Much Debt Does Akari Therapeutics PLC Have?
Total long term debt quarterly is $0 -
How Much Cash Does Akari Therapeutics PLC Have?
Cash and short term investments quarterly total is $4.2M -
What Is Akari Therapeutics PLC’s Book Value Per Share?
Book value per share is -0.30
Is Akari Therapeutics PLC Cash Flow Positive?
-
What Is AKTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$18.5M -
What Is Akari Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.8M -
What Is Akari Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Akari Therapeutics PLC Return On Invested Capital
Data Unavailable
Akari Therapeutics PLC Earnings Date & Stock Price
-
What Is Akari Therapeutics PLC's Stock Price Today?
A single share of AKTX can be purchased today for 2.24 -
What Is Akari Therapeutics PLC’s Stock Symbol?
Akari Therapeutics PLC trades on the nasdaq under the ticker symbol: AKTX -
When Is Akari Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Akari Therapeutics PLC is scheduled on April 1, 2025 -
When Is AKTX's next ex-dividend date?
Akari Therapeutics PLC's next ex-dividend date is May 26, 2020 -
How To Buy Akari Therapeutics PLC Stock?
You can buy Akari Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akari Therapeutics PLC Competitors
-
Who Are Akari Therapeutics PLC's Competitors?
Below is a list of companies who compete with Akari Therapeutics PLC or are related in some way:
Akari Therapeutics PLC Dividend Yield
-
What Is AKTX Dividend Yield?
Akari Therapeutics PLC’s dividend yield currently is 0% -
What Is Akari Therapeutics PLC’s Payout Ratio?
Akari Therapeutics PLC’s payout ratio is 0% -
When Did Akari Therapeutics PLC Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Akari Therapeutics PLC’s Dividend Per Share?
Akari Therapeutics PLC pays a dividend of $0.00 per share
Akari Therapeutics PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 100% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 80.00 |
| Upside from Last Price: | 3471.43% |